70.下列預防器官排斥之藥品組合,何者最不適當?[註:AZA: azathioprine; CSA: cyclosporine; MMF:
mycophenolate mofetil ; SRL: sirolimus; TAC: tacrolimus ]
(A)CSA+AZA+prednisolone
(B)CSA+TAC+MMF
(C)TAC+MMF+prednisolone
(D)TAC+SRL+prednisolone
答案:登入後查看
統計: A(234), B(2211), C(175), D(1107), E(0) #2623995
統計: A(234), B(2211), C(175), D(1107), E(0) #2623995
詳解 (共 10 筆)
#4873891
我的想法:
tacrolimus跟cyclosporin都是Calcineurin inhibitors (CNI)
通常不會併用同機轉的
所以選B
203
1
#6110801
補充:(D)選項TAC+SRL+prednisolone是移植病人如果在使用免疫抑制劑後有出現BK virus感染會改用這個組合,把MMF換成m-TOR抑制(sirolimus)並調低tarcrolimus的劑量,TDM濃度也要做調整,某一派是說TRC+SRL=8,給大家參考
10
0
#6153565
Immunosuppressant
Induction therapy 【Basiliximab (anti-CD25) or Other agents rATG, Alemtuzumab】
+
(1) General Combination:CNI (FK 506(Tacrolimus)/CsA)+ Anti-metabolites (MPA/AZA) + Steroids
(2) Other agents:mTOR inhibitor Sirolimus /Everolimus
----
Steroid-free regimen
1.reduce metabolic burden
2.high risk of rejection
3.Stronger induction therapy is warranted (Alemtuzumab)
4
0
#6093230
72.下列何者不適用於治療急性antibody-mediated rejection?
(A) azathioprine
(B) antithymocyte globulin(ATG)
(C) corticosteroid
(D) intravenous immunoglobulin(IVIG)
ㅤㅤ
答案:A
ㅤㅤ
72.下列何者為治療急性cellular rejection之第一線用藥?
(A) basiliximab
(B) antithymocyte globulin
(C) corticosteroid
(D) alemtuzumab
ㅤㅤ
答案:C
4
2